What question did this study set out to answer?

This study aims to explore the long-term effects of monoclonal antibody therapy on central nervous system recovery in rabies disease.

Monoclonal antibody therapy for rabies disease: long term impact on central nervous system recovery 2257695

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates motor function recovery and CNS damage in rabies-afflicted animals, highlighting persistent challenges.

This study aims to explore the long-term effects of monoclonal antibody therapy on central nervous system recovery in rabies disease.
Utilized a mouse model of lethal rabies disease.
Administered human monoclonal antibody A6 to evaluate its effects on motor function and CNS damage.
Conducted immunohistochemistry on tissue samples to assess blood brain barrier integrity and underlying mechanisms.
A6 treatment improved motor function during the acute phase but showed significant impairment compared to uninfected controls in the post-recovery phase.
Initial results indicate diminished blood brain barrier function in both infected untreated and A6-treated animals.
Evidence suggests structural CNS damage may be permanent despite rescue from mortality and partial recovery.

Rader et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark